EGFR and head and neck squamous cell carcinoma: We compared the distribution of tumor site, clinical T, histological N and mitotic index for two groups of head and neck squamous cell carcinomas (those with p53+ and EGFR-, versus the remaining patients) and no distribution bias was detected.